Study documentation part: Visits 1 (Screening), Study week -4 to 0 Study Details: A 24-week, multicenter, exploratory, two arm study to assess the effect of Dimethyl fumarate on ImmuneModulatory Action on T cells in patients with relapsing remitting Multiple Sclerosis. Principal Investigator PD Dr. Luisa Klotz, University Hospital Münster EudraCT - No.: 2014-003481-25. Clinical Trial No.r: NCT02461069.

Versions (3) ▾
  1. 9/17/15
  2. 9/22/15
  3. 5/24/16
Uploaded on:

May 24, 2016

No DOI assigned. To request one pleaselog in.
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Visit 1 (Screening) Part 1/2, DIMAT-MS, Relapsing Remitting Multiple Sclerosis DRKS00008037 NCT02461069

Visit 1 (Screening) Part 1/2, DIMAT-MS, Relapsing Remitting Multiple Sclerosis NCT02461069

Administration and Instructions for CRF Completion
Demographic Data
Blood pregnancy test
Blood pregnancy test not done, reason:
Testing for JC virus antibodies
Medical History
Ongoing at Start of Study
MS Medical History
Date of MS diagnosis unknown
Date of first MS symptoms unknown
Number of relapses in the last 12 months unknown
MS Treatment History
Active substance/nondrug therapy
Treatment of MS relapse